Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mankind Pharma Ltd. ( (IN:MANKIND) ) just unveiled an update.
Mankind Pharma Ltd. has announced a Board meeting scheduled for July 31, 2025, to discuss and approve the unaudited financial results for the quarter ending June 30, 2025, and to consider the declaration of an interim dividend for the financial year 2025-26. The trading window for the company’s securities will remain closed until August 2, 2025, as per insider trading regulations, which may impact stakeholders’ trading activities.
More about Mankind Pharma Ltd.
Mankind Pharma Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company is known for its commitment to affordable healthcare solutions and has a significant presence in the Indian market.
Average Trading Volume: 18,587
Current Market Cap: 1064B INR
Find detailed analytics on MANKIND stock on TipRanks’ Stock Analysis page.